BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28550310)

  • 1. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme.
    Paul D; Sinha AN; Ray A; Lal M; Nayak S; Sharma A; Mehani B; Mukherjee D; Laddha SV; Suri A; Sarkar C; Mukhopadhyay A
    Sci Rep; 2017 May; 7(1):2466. PubMed ID: 28550310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
    Cesarini V; Silvestris DA; Tassinari V; Tomaselli S; Alon S; Eisenberg E; Locatelli F; Gallo A
    Nucleic Acids Res; 2018 Feb; 46(4):2045-2059. PubMed ID: 29267965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
    Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
    Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
    Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
    Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.
    Choudhury Y; Tay FC; Lam DH; Sandanaraj E; Tang C; Ang BT; Wang S
    J Clin Invest; 2012 Nov; 122(11):4059-76. PubMed ID: 23093778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR2 induces reproducible changes in sequence and abundance of mature microRNAs in the mouse brain.
    Vesely C; Tauber S; Sedlazeck FJ; Tajaddod M; von Haeseler A; Jantsch MF
    Nucleic Acids Res; 2014 Oct; 42(19):12155-68. PubMed ID: 25260591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-Inosine Editing of MicroRNA-487b Alters Target Gene Selection After Ischemia and Promotes Neovascularization.
    van der Kwast RVCT; van Ingen E; Parma L; Peters HAB; Quax PHA; Nossent AY
    Circ Res; 2018 Feb; 122(3):444-456. PubMed ID: 29284691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
    Shoshan E; Mobley AK; Braeuer RR; Kamiya T; Huang L; Vasquez ME; Salameh A; Lee HJ; Kim SJ; Ivan C; Velazquez-Torres G; Nip KM; Zhu K; Brooks D; Jones SJ; Birol I; Mosqueda M; Wen YY; Eterovic AK; Sood AK; Hwu P; Gershenwald JE; Robertson AG; Calin GA; Markel G; Fidler IJ; Bar-Eli M
    Nat Cell Biol; 2015 Mar; 17(3):311-21. PubMed ID: 25686251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma.
    Silvestris DA; Picardi E; Cesarini V; Fosso B; Mangraviti N; Massimi L; Martini M; Pesole G; Locatelli F; Gallo A
    Genome Biol; 2019 Feb; 20(1):33. PubMed ID: 30760294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of edited microRNAs in the human brain.
    Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
    Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism.
    Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M
    J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and fate of microRNA editing in human brain.
    Kawahara Y; Megraw M; Kreider E; Iizasa H; Valente L; Hatzigeorgiou AG; Nishikura K
    Nucleic Acids Res; 2008 Sep; 36(16):5270-80. PubMed ID: 18684997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
    Tassinari V; Cesarini V; Silvestris DA; Gallo A
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-to-I editing of microRNAs in the mammalian brain increases during development.
    Ekdahl Y; Farahani HS; Behm M; Lagergren J; Öhman M
    Genome Res; 2012 Aug; 22(8):1477-87. PubMed ID: 22645261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.